Nucleolin: a nuclear Akt substrate Etro, Daniela; Missiroli, Silvia; Neri, Luca Maria; Capitani, Silvano dettagli >>	il sedicesimo - Firenze, Italian Journal of Anatomy and Embryology pp: 90-90, Anno: 2006

The erythroid differentiation of K562 cells depends on the nuclear translocation of Akt Missiroli, Silvia; Etro, Daniela; Neri, Luca Maria; Capitani, Silvano dettagli >>	il sedicesimo - Firenze, ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY pp: 183-183, Anno: 2006

Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 Capitani, Silvano; Corallini, Federica; Previati, Maurizio; Carini, Cinzia; Seraceni, Silva; Contini, Carlo	Anlaids, unico Vol. -, No. 1, pp: ---, Anno: 2005

Deregulated microRNAs in breast ductal carcinoma in situ (DCIS) with invasive propensity Volinia, S.; Bertagnolo, V.; Brugnoli, F.; Grassilli, S.; Galasso, M.; Scatena, C.; Lessi, F.; Croce, C. M.; Capitani, S.	ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, EUROPEAN JOURNAL OF CANCER pp: 32-32, Anno: 2016

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent AKT reactivation. Simioni, C; Cani, A; Martelli, Am; Zauli, G; Capitani, S; Neri, Lm dettagli >>	AMER ASSOC CANCER RESEARCH, MOLECULAR CANCER THERAPEUTICS Vol. 14 Supplement: S, No. 1, pp: 1-1, Anno: 2015

Therapeutic potential of the novel mTOR inhibitor Torin-2 to overcome AKT reactivation in B-precursor acute lymphoblastic leukemia (B-pre ALL). Cani, A.; Simioni, C.; Martelli, A. M.; Zauli, G.; Capitani, S.; Neri, L. M. dettagli >>	AMER ASSOC CANCER RESEARCH, -- Vol. 21 Supplement: 17, No. 1, pp: 1-1, Anno: 2015

The mTOR inhibitor, RAD001, displays higher cytotoxicity in leukemias with hyperactivated PI3K/AKT/mTOR pathway Cani, A.; Simioni, C.; Capitani, S.; Martelli, A. M.; Neri, L. M. dettagli >>	AMER ASSOC CANCER RESEARCH, -- Vol. 72 Supplement: 8, No. 1, pp: 1-1, Anno: 2012

The novel Akt inhibitor MK-2206, is cytotoxic in T-cell acute lymphoblastic leukemia: Therapeutic implications Simioni, C.; Cani, A.; Bressanin, D.; Evangelisti, C.; Chiarini, F.; Capitani, S.; Neri, L. M.; Martelli, A. M. dettagli >>	AMER ASSOC CANCER RESEARCH, -- Vol. 72, No. 1, pp: 1-1, Anno: 2012

Vav1 regulates phenotypic differentiation of AML-derived promyelocytes to monocytes/macrophages Nika, E.; Brugnoli, F.; Bonora, M.; Grassilli, S.; Palomba, M.; Capitani, S.; Bertagnolo, V	WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, FEBS JOURNAL Vol. 278, No. 1, pp: 241-241, Anno: 2011

ROLE OF VAV1 IN DIFFERENTIATION ALONG THE MONOCYTIC-MACROPHAGIC LINEAGE OF TUMORAL MYELOID PRECURSORS Nika, E.; Brugnoli, F.; Grassilli, S.; Capitani, S.; Bertagnolo, V	WILEY-LISS, DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA, CYTOMETRY PART A Vol. 77A, No. 2, pp: 198-199, Anno: 2010